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Background: Formaldehyde (HCHO) is a gas (available as a 37% concentrated solution, stabilized with methanol).
The 10% dilution (approximately 4% formaldehyde) has been used as a fixative since the end of the 19th century.
Alternative fixatives are also commercially available or may be prepared in-house in laboratories. Statements by the
IARC, along with other USA agencies (CalEPA, RoC/NTP) on the carcinogenicity of formaldehyde for humans renders
its substitution in Pathology Departments necessary since the annual use of formalin may exceed 3,500 liters for a
medium-large laboratory.
To achieve a “formalin-free laboratory” we tested straightforward-to-make fixatives along with registered reagents
offered as formalin substitutes.
Methods: More than two hundreds specimens were fixed in parallel with in-laboratory made fixatives PAGA
(Polyethylenglycol, ethyl Alcohol, Glycerol, Acetic acid), two zinc-based fixatives (ZBF, Z7), and commercially-
available alternatives (RCL2 and CellBlock). Tissue micro arrays were used for morphological and
immunohistochemical comparison. Extraction of RNA was carried out to evaluate preservation of nucleic acids.
Results: Differences compared to formalin fixation were evident in alcohol-based fixatives, mainly restricted to
higher stain affinity and considerable tissue shrinkage. Conversely, nuclear detail was superior with these alcohol-
based formulas compared to formalin or glyoxale-based recipes. RNA extraction was superior for Z7, PAGA and
RCL2 with regard to concentration but relatively comparable regarding quality.
Conclusions: Abolition of the human carcinogen formaldehyde from pathology laboratories is possible even in
contexts whereby commercial alternatives to formalin are unavailable or are too expensive for routine use, and
aspiration devices are lacking or not adequately serviced. The use of known formulations, possibly with simple and
not-noxious (“alimentary grade”) constituents, comparable with registered proprietary products, may expand the
search for the ideal fixative combining satisfactory morphology with improved preservation of nucleic acids and
proteins as well as being easy and safe to dispose of.
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Fixation is a key step in the practice of diagnostic path-
ology, and even in modern times, is intimately linked to
the use of formaldehyde (HCHO), a gas commercially
available in concentrated solution (37%), stabilized with
ethanol, and named Formalin. A 10% dilution of concen-
trated formalin (in tap water or buffers with final concen-
trations of formaldehyde of approximately 4%) is named
10% formalin [1,2].
The main motives for the popularity of formalin
among pathologists are: low cost, straightforward labora-
tory preparation procedure, long-standing tradition and
international use.
There is a general consensus that formalin is the best
fixative and there is therefore no need for improvement
for any reason, generating what has been defined by some
authors as “the formalin dogma” [3], a somewhat fatalistic
and “addictive” approach that has severely hampered the
search for alternatives to formalin in fixation procedures.
Political changes in recent decades, along with the gen-
eralized shift towards a “market-regulated economy”,
have introduced economy-driven research, and the pro-
prietary use of innovative and scientific observations,
along with a more open approach as well as the free ex-
change of scientific knowledge. However, the free mar-
keting of alternative fixatives with registered and
proprietary formulas have in fact acted as an obstacle to
the diffusion and sustained use of registered products [4].
It has also discouraged the quest and testing of formalin
substitutes for every-day use, and the widespread scien-
tific research and investigation into new fixatives.
The toxicity of formaldehyde is emerging as the main
issue for its abolition as a general fixative used in large
quantities in pathology laboratories (a medium-large
structure may annually use more than 3,500 liters of
ready-to-use formalin).
In 1987, the U.S. Environmental Protection Agency
(EPA) classified formaldehyde as a probable human car-
cinogen under conditions of unusually high or prolonged
exposure [5] and a few years later the permissible expos-
ure level was lowered from 1 ppm to 0.75 ppm (average
daily exposure) [6] and the potential toxicity of formal-
dehyde exposure to technicians and pathologists was
stressed, meanwhile promoting the search for alternative
fixatives.
More recently, from the initial IARC report linking for-
maldehyde exposure to human nasopharyngeal carcin-
oma [7], a successive link between formaldehyde
exposure and leukemia was put forward in 2009 [8];
these statements were reinforced in the 2012 report [9]
by the same agency. These data of the carcinogenicity for
humans of formaldehyde should act as a potent stimulus
to reconsider the “formalin dogma” and to evaluate with
an open mind the use of alternative fixatives.The U.S. Occupational Safety and Health Administra-
tion (OSHA) stated that employers must reduce worker
exposure to formaldehyde at, or below, permissible
exposure limits (PEL) and the TWA (time-weighted
average) should be less than or equal to 0.75 ppm. The
15-min short term exposure limit (STEL) is 2 ppm.[10].
International and National agencies set stringent limits
of formaldehyde exposure ranging from 0.016 ppm TWA
(National Institute for Occupational Safety and Health,
USA) to 2 ppm (OSHA and Australia) for STEL [11].
Moreover, the formation of DNA-Protein cross-links
(DPC or DPX) possibly represents a permanent “signa-
ture” of exposition to formalin [12]. More recently
chromosomal alterations have been detected in health
workers and linked to formalin use in Pathology Wards
[13]. This information was largely ignored by the path-
ologist community who assumed that the use of formal-
dehyde as a fixative is mandatory and thus completely
safe when used with adequate procedures [14].
Recent reports comparing a group of pathologists
and industrial workers, and using individual devices to
monitor exposure to formaldehyde demonstrated that
environmental exposure in pathology departments is
trivial in most areas while the sampling activity in the
gross room may result in exposure to toxic levels that
exceed the recommended values [15,16]. Individual ex-
posure to formaldehyde was monitored by measuring
Malondialdehyde-deoxyguanosine adducts on periph-
eral leukocytes and the alkylation of hemoglobin to
form a terminal N-methylene valine residue. These
data show that formaldehyde exposure in the gross
room is comparable to that of workers in plastic fac-
tories and that perfectly efficient aspiration devices
may not in fact avoid individual exposure.
Nevertheless, law restrictions on the use of human
carcinogenic substances, mainly directed at industrial
production and use, are also valid for pathology labora-
tories. In Italy, safety labels on formaldehyde prepara-
tions have not changed from irritant (X) to carcinogenic
substance (skull pictogram). One of the aims of our
study is to clarify the necessity of general awareness of
the scientific and ethical issues related to the abolition of
formaldehyde use in pathology laboratories, and to con-
tribute to the quest for valid alternatives, either home-
made or commercially-available.
On the other hand, this classification into a Class I
substance makes surveillance of exposed personal
mandatory, and may involve Directors of Surgical
Pathology Departments as well as Hospital Administra-
tors responsible for the health of workers. The delay
in introducing this new information as a National
Standard has led to the generation of the idea that the
IARC warning was limited to industrial environments
and not mandatory for pathology laboratories.
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81/2008) clearly states that carcinogens should only be
used in closed work-cycles and must be substituted
when technically possible (Art. 235). European Union
legislation is moving in the same direction.
While industries (e.g. wood and furniture) are rapidly
adhering to law prescriptions (and are certifying the
absence of formaldehyde vapors), in the medical field
an unusual delay is still present.
A rational, open-minded and innovative approach to
fixation, with the scope of abolishing formalin use
altogether, [17,18] or at least limiting its use to very rare
situations in which there are no available alternatives
(like Formaldehyde-induced fluorescence for Catelchola-
mines or formaldehyde-vapor fixation in certain histo-
enzymatic determinations [1]).
The use of formalin in surgical pathology labora-
tories may be partially justified by the large size of
the surgical specimen, putatively easier to handle
after formalin fixation and supposedly better fixed in
comparison to alternative fixatives. However, it must
be stressed that manipulation of large resection
materials, along with increasing demands of more
detailed macroscopical descriptions and extended
sampling (as required by modern staging of tumors)
may increase the exposure of pathologists to formal-
dehyde vapors.
However, when studying experimental animals of small
dimensions no rational explanation may be proposed for
the continuation of the use of formalin-fixed tissue for
microscopical evaluation.
Nevertheless, the National Toxicology Program of the
U.S. – probably the largest program in this field -
requires the use of buffered formalin [19]. Conversely, an
European Institution (Cesare Maltoni Cancer Research
Center, European Ramazzini Foundation of Oncology
and Environmental Sciences, Bologna, Italy. crcfr@ra-
mazzini.it) suggests alcoholic fixation of all organs of rats
apart from bones [20]. Curiously, for de-calcification the
same protocol suggest a solution containing formalde-
hyde and formic acid, despite there being several
formaldehyde-free methods of decalcification available,
as reported in literature and on the market.
As these formaldehyde-free procedures are effective
in human pathology for large bony samples, there is no
logical reason for the continued use of formaldehyde -
formic acid formulations for decalcification of bones of
much smaller experimental animals.
A second more recent, but preeminent issue, is the
search for a more effective way of fixing tissues in order
to preserve nucleic acids and proteins for molecular
biology techniques [21-25], with the perspective of
utilization of the vast surgical pathology archives of tis-
sues, for scientific research on tumors or other relevanthuman diseases, and to integrate these determinations
into clinical diagnoses.
The importance of good preservation of tissues, not
only for microscopic evaluation, but also for Histochem-
istry, Immunohistochemistry and Molecular Biology is
taken into consideration [17,21,26,27]. The fatalistic
approach is that that once a specimen is dropped in for-
malin, no other manipulations or control procedures are
necessary. This is the case even for very large specimens
that will never be adequately fixed in their central parts
unless proper slicing (or alternative maneuvers) is
applied. It is also given a low profile which underesti-
mates the potential of new tools (like nucleic acid tech-
nology or proteomics) in the diagnostic process.
As highlighted in a study on the influence of fixation
and processing parameters [28], the final fixation of
many tissue of large specimens primarily fixed with for-
malin is frequently achieved during processing and is ac-
tually an alcoholic fixation. This note - contrary to
efforts to standardize formaldehyde fixation and proces-
sing [29] - is a further argument against the “formalin
dogma”, but it also an important rational explanation of
the fact that paraffin-embedded tissues are very stable
and that tissue reactivity is influenced by primary fixa-
tive, but is stabilized by alcoholic dehydration and clear-
ing before embedding. For instance, the deleterious
action of Picric Acid (a constituent of Bouin's Fixative)
mainly affects DNA bases and is not related to improper
fixation.
Is worth noting that a practical application of the “for-
malin dogma”, the acronym FFPE (formalin- fixed paraf-
fin embedded) enforced the dogma than no other
fixative but formalin should be used [29].
The use of microwaves may be a interesting way for
obtaining a better fixation either as a step in fixation–
processing procedures, or as an upgrade of automatic
processing instruments.
Commercially-available alternatives to formalin are
fairly numerous and in different supply formats either
ready-for-use or in concentrated forms. While ready-
to–use formulas are very convenient, concentrated for-
mulas may allow some degree of manipulation and
custom tailored modifications.
As noted by Kiernan [1] the use of “secret mixtures”,
that is- the registered proprietary formulas of poorly
detailed components- is a severe limitation to a rigorous
scientific approach to fixation, and despite being expen-
sive, may be a straightforward solution, at least in the
short term.
Less numerous are the non- proprietary formulas pro-
posed in recent scientific literature while the wealth of
information on time-honored fixatives reported in scien-
tific journals and histochemistry text books may be
worth revisiting as they give useful clues for new
Zanini et al. Environmental Health 2012, 11:59 Page 4 of 14
http://www.ehjournal.net/content/11/1/59improvements. The use of Zinc salt-based fixatives as
alternatives to formalin was recently reported by a
Swedish group [30] and subsequently upgraded by
other scientists [31].
The availability of commercial alternatives to formalin
is mainly restricted to Western countries, being wide-
spread in North America, and to a lesser degree in
Europe. The possibility of preparing effective substi-
tutes in the laboratory may be of particular interest,
considering the high cost of an effective and durable
aspiration chain of formalin vapors (from aspiration
hoods, aspirated cabinets and final proper disposal), and
the limited economical resources of developing countries
that frequently lack proper servicing of instruments [32].
The low cost of formalin, being less expensive than
brand substitute products, and also being readily avail-
able in the market by many suppliers and in different
convenient formats has hampered the diffusion and re-
search of alternatives. Indirect costs of formalin fixation
(for example: adequate disposal of used fixative and fixed
specimens; potential toxicity of products from inciner-
ation of residual specimens; and the imperative necessity
of perfect maintenance of aspirations devices, such as
hoods and aspirated cabinets) should also be considered
in economical evaluation of costs. Moreover the neces-
sity of adequate health surveillance of workers exposed
to a human carcinogen should be also considered as an
additional and non-trivial economical cost.
Recently, new devices were proposed by industrial
firms to avoid the exposure to formaldehyde in pathology
laboratories during grossing activities [33,34] however a
more radical approach for completely abolishing formal-
dehyde and for obligatory use of alternative fixatives not
based on gas in solution seems more appropriate.
In the present study we started from the standard
practice of our pathology laboratory at the Ospedale In-
fantile Regina Margherita (OIRM) disestablished in
2009, in which formalin use as a fixative was limited to
autopsy practice, a small activity in comparison to hist-
ology and cytology.
The decision to substitute formalin was the only
available possibility to protect lab personnel from gas
exposure when faced with the refusal of the hospital
administration board to upgrade the aspiration hoods
in a reasonable time.
From 1992, formalin was substituted with a commer-
cial formula distributed in Italy as “Biolina” but corre-
sponding to “Histochoice” (Amresco, OH, USA). This
glyoxale-based fixative with ethyl alcohol (20-40% in the
ready-to-use fixative) gave an acceptable morphology in
our hands, and was used for almost 3 years as a routine
fixative. In the gradual process of formalin substitution,
0.5 ml of methylene blue was added to a liter of Biolina,
obtaining a light blue color. This simple methodpermitted detection, at a glance, of the presence of the
substitute fixative, and avoided the use of smelling when
in doubt. The use of this “light blue fixative” was widely
accepted, especially in surgical theaters. In the autopsy
practice, Biolina was unsatisfactory due to a slower tissue
penetration and the lack of tissue hardening that made
further trimming difficult. Therefore, Formalin use was
limited to post-mortem examinations with cautious pro-
cedures to limit vapor diffusion.
In order to protect the proprietary formula, the safety
sheet did not fulfill the European standards on safety
instructions for chemical products for laboratory or in-
dustrial use (16 points are required to be clearly stated)
[35]. Subsequently Biolina was retracted from commer-
cial use in Italy, and all known deposits of the reagent
were sequestrated.
Abruptly, it was necessary to face a difficult situation
in which no commercial alternative was available in the
national market, and the temptation to return to forma-
lin was therefore very high.
From a rapid consultation of the scientific literature
we discovered the interesting investigations of Bostwick
[4] with a commercial substitute of formalin (Stat Fix).
From the published components, we were able to pre-
pare a mixture of PolyethylenGlycol (PEG), acetic Acid,
Glycerol and ethyl alcohol (PAGA) in the lab, and this
formulation was used with decent morphological results
and no problems in Immunohistochemistry or Histo-
chemistry. For almost one year PAGA was used in the
substitution of formalin. Although PAGA was satisfac-
tory as a routine fixative and not particularly expensive,
an abrupt shortage of technical help led to a shift to a
commercial alternative to formalin. No-Tox (EarthSafe
Industries, Inc., Belle Mead, NJ 08502), a new commer-
cial substitute of formalin was introduced in the market
and was available in Italy. Unfortunately some difficulties
were encountered with Immunohistochemistry (particu-
larly Mib-1) and no suggestions were available from the
producer in order to resolve this staining problem, and
antigen retrieval experience was still limited [28,36]. We
tested another new substitute of formalin, produced and
marketed by Merck (Neo-Fix), which was an alcohol-
based fixative (50% ethyl alcohol) and PEG. Since tissue
shrinking was still acceptable and Mib-1 was easily
detected, we shifted to the use of Neo-Fix and used it
for more than 6 years, but due to commercial problems
this fixative was no longer commercially available in Italy
at the end of 2003. At that time we tested the commer-
cially available alternatives to formalin present in the
Italian market and selected FineFixx (Milestone, Italy) as
the most suitable. FineFixx is an isopropyl and ethylic
alcohol-based fixative (70% ethyl alcohol and tensioac-
tive agents). The high alcohol percentage has evident
shrinking artifacts but, despite this, morphology is
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were also satisfactory.
In the quest for formaldehyde abolition, we also faced
the problem of finding an effective substitute for the
formaldehyde-formic acid mixture for a de-calcifying
formula suitable for large orthopedic specimens. We
obtained the recipe of de-calcifying fluid that was used
routinely at the Surgical Pathology Dept. of Pini Ortho-
pedic Hospital of Milan (Italy) (courtesy of A. Parafioriti
M.D.) This method, based on Formic and Hydrochloric
acids, was as effective as the former and easy to prepare
in the laboratory.
Materials and methods
The study was reviewed and approved by the Institu-
tional board of the Molecular Biotechnology Center of
the University of Turin, Italy.
In the present study we compared different commercial
or laboratory prepared fixatives to the standard fixation
protocols used in the laboratory for routine histology
(FineFixx - Carnoy – B5).
The commercially fixatives tested included Cell-Block
(Bio-Optica, Italy), as a Glyoxale - Ethyl Alcohol fixative;
RCL2, a French proprietary formula based on Acetic
Acid, Ethyl alcohol and non-reducing Carbohydrates
(Celbio, Italy). The non-proprietary fixatives were pre-
pared in our laboratory and tested: Zinc-based (ZBF and
Z7), PAGA and derivatives with or without added
buffers.
More than 200 inclusions using strict fixation proto-
cols were prepared from surgical pathology specimens in
which fresh tissue in excess of the diagnostic needs and
protocol suggestions were available, as well as some aut-
opsies in which the delay was not exceeding 24–36 hours
after death. The diagnostic material was fixed in the
routinely-used fixative. In a few cases (mainly autopsies)
formalin-fixed blocks were prepared using a commercial
buffered formalin (Histoline, Italy).
Fresh tissues were sliced at the thickness of 5 mm
using a grossing board with different depth-cutting possi-
bilities (Bio-Optica, Italy).
Tissues were immediately immersed in the different
fixatives and routinely processed the following day (for
the samples prepared on Friday the action of the fixatives
was increased to 72 hours and subsequent processing
steps were started the following Monday). Adjacent slices
were immersed in different fixatives avoiding necrotic
areas in order to standardize the sampling procedures
and allow a valid morphological comparison.
Fixation tissues were then transferred to 70° ethyl al-
cohol and processed with routine blocks in a Shandon
Excelsior processor. The protocol of dehydration –
clarification and paraffin immersion was tailored for
non-formalin fixation, as already in use for FineFixx.The commercially-available fixatives tested Cell-Block
(Bio-Optica, Italy), RCL2 (Celbio, Italy), Neo-Fix (Merck,
Italy), were obtained by the producers or sale representa-
tives as trial samples, as far as commercially available.
For homemade recipes, Zinc Fixatives (ZBF and Z7),
PAGA and PAGA-T were prepared according to the sci-
entific literature [4,30,31]. FineFixx (Milestone, Italy),
routinely used as a general fixative, served as a compari-
son [23]. For neurosurgical specimens, Carnoy's fixative
was utilized [37].
For tissue from post-mortem examinations, formalin-
fixed samples were available for comparison.
Staining
Routine H&E was performed on slides using an auto-
matic histology stainer (Leica, Italy) and the standard
staining protocol for Fine-Fix fixed tissue was used.
Giemsa, trichromic stain and Alcian blue (pH 1 and pH
2,5) PAS were also performed.
Tissue micro array
Tissue micro arrays (TMA) were prepared using 3DHis-
tec TMA Master. Acceptor blocks were designed to in-
clude 68 holes of 1.5 mm, and punching was then
accomplished from all tissues from available blocks. A
total of 5 TMA were prepared and cut.
Slides were then used for a morphological comparison
of the performance of the different fixatives on a reduced
number of slides in order to limit batch variability of
staining.
TMA was also used to sample selected blocks for
RNA extraction: four 1 mm cores were punched out
from each block and extracted according to a tested
protocol in use.
Morphological evaluation
H&E stained sections from all inclusions were evaluated
for different aspects of tissue and cellular details. The
use of TMA for morphological comparison abolished
the normal variation of staining intensity due to fading
over time (fortnight substitution).
For comparisons, corresponding tissues were used that
were fixed with the non-formalin fixatives used for rou-
tine diagnostic work. Fine-Fix was the reference fixative
for most sampled cases, but Carnoy and B5 fixed speci-
mens also entered into the comparison with the chal-
lenged fixatives.
Immunohistochemistry
Routine immunohistochemistry was performed on non-
formalin fixed tissues utilizing a Ventana Benchmark
automated stainer and pre-diluted primary antibodies
from Ventana, where available and when suitable for
non-formalin fixation. In general, antigen-retrieval
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highly sensitivity reactive agents. In a few cases, antibodies
from different producers were used with the Benchmark
stainer, either because they were unavailable from Ven-
tana, or for substituting pre-diluted antibodies that gave
unsatisfactory results (e.g. Baf47 from BD Buccinasco,
Italy and WT-1 from Thermo Scientific, Aalst Belgium).
We had no problems in tailoring automated Immuno-
histochemistry, having already worked with Fine-Fix, to
give acceptable results on the fixatives used in the
present study.
RNA extraction
Ten selected blocks of the same specimen were sampled
for RNA extraction using four 1 mm cores punched out
from tissue blocks with TMA Master.
Tissue cores were de-paraffinized with two passages in
xylene, transferred to absolute ethanol, followed by 90%
ethanol and then 70% ethanol. After spinning for 20 min-
utes at 4°C at 14,000 rpm pellets were warmed for 30 min-
utes at 37 C° (or until all ethanol had evaporated). Then,
200 μl of Digestion Buffer 1X with β-Mercaptoethanol
(0.2%, final concentration) and Proteinase K (6 mg/ml,
final concentration) were added. Samples were incubated
overnight at 55°C, with gentle mechanical shaking.
A volume of Phenol/Chloroform mixture (7:3 v/v) was
added to each sample, and tubes were gently mixed by
inversion and incubated for 20 minutes on ice. Samples
were spun for 20 minutes at 4°C at 14,000 rpm, and
supernatants were then transferred to clean tubes and
this procedure was repeated twice [38].
Samples were subsequently transferred to new tubes
containing 5 μl of glycogen (1 mg/ml), precipitated with
3 volumes of ethanol-LiCl, and incubated overnight at –
20°C.
The following day, samples were spun for 20 minutes
at 4°C at 14,000 rpm, and supernatants were discarded.
Pellets were washed once with 70% ethanol, left to dry
at room temperature, and finally resuspended in 25 μl of
DEPC water.Figure 1 Macroscopic aspect of fixation. Tissue fragments still immersed
following fixation, and within the biopsy cassette (right). Z7 tissue retains th
variations in color. It is important to be aware of and remember the differe
on discoloration to judge the final point of fixation. Some alcohol-based fix
colors.RNA concentration was determined at 260 nm and
280 nm with a Thermo Scientific Nanodrop 2000 spec-
trophotometer (EuroClone, Italy).
RNA samples were also tested for their quality using
the RNA 6000 LabChip kit (Agilent Technologies) fol-
lowing the manufacturer’s instructions, and RNA ana-
lysis was evaluated with the 2100 Bioanalyzer (Agilent
Technologies). This instrument performs electrophoresis
for each RNA sample and delivers an RNA integrity
number (RIN).
Results
Macroscopical aspects of overnight fixation are shown in
Figure 1. The action of each fixative modifies several
physical characteristics of the samples in a unique way.
Color and consistence are evident at a glance, while
other features such as shrinkage and surface modifica-
tions are more subtle. In disagreement with a recent
paper [39] that reported some difficulties in handling
and sectioning of samples fixed in RCL2, we did not en-
counter any problems in these preparative aspects. The
embedding process that follows fixation may largely
modify the physical qualities of samples to be included
in paraffin, and influence the ease in sectioning. As
already stated, we used non-formalin fixatives for routine
surgical specimen processing, so conditions were already
set for non-formalin fixation.
A possible pitfall in processing may be over-
dehydration related to over-timing of absolute alcohol
exposure of tissues with less water content due to
alcohol-based fixatives.
The high alcoholic concentration of some fixatives
(FineFixx and RCL) may conflict with the automatic re-
agent turnover used in the Shandon - Thermo Excelsior
tissue processor (Italscientifica, Italy) since it is based on
dilution of alcoholic grade of the first dehydration bath
and alcohol rotation.
In our experience, this possible technical pitfall is not
clearly stated in the instruction manual of the instru-
ment and may cause poor tissue processing due toin different fixatives after 16 hours (left); detail of Z7 fixed tissue
e original color of unfixed specimens while other samples show
nce of color modifications typical of each fixative, and not to only rely
atives (like FineFixx) are second only to Z7 in the preservation of
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mendation, when shifting from formalin to alcoholic
substitutes, is to check the schedule of dehydrating
agents in the tissue processor instrument and not to rely
on alcoholometric-driven automatism since inaccurate
dilution of alcohols will be detected.
It may be important to underscore that color preserva-
tion may be good enough to give the impression of inad-
equate fixation if discoloration is assumed to be a
reliable sign of proper fixation. This phenomenon is
present in many alcohol-based fixatives but is particu-
larly striking with Z7, a mixture of Zinc salts.
In general, alcohol-based fixatives do not change color
in the same way as formalin does. The modification of
color may be generally used to control the process of fix-
ation. Zinc salts as well as ethyl alcohol do not alter re-
spiratory enzymes and oxygen-carrier proteins like
hemoglobin and myoglobin which means that color fad-
ing (as induced by formalin action on tissues) is not
induced by these chemical compounds and, especially
with Z7, perfectly fixed tissue specimens preserve their
original colors (Figure 1 right). Not being accustomed to
these different macroscopic modifications of fixatives
may induce the operator to interpret the lack of color
modification as inadequate fixation and possibly prolong
the fixation time.
An unusual phenomenon, only observed a few times,
and just in the case of ZBF, was the development of
molds on the top of the container (Figure 2). Although
no apparent deterioration of the residual tissue was evi-
dent, this possible fungal growth on the surface of the
fixative is undesirable.
Morphology: Dye affinity alcohol-based fixatives, as
well as Zinc-based ones, convey a higher affinity for dyes
to the sections, especially Eosin, in comparison with
neutral-buffered formalin or Glyoxale-based formulas.
Nuclear structure is better preserved in alcohol-based
fixatives. Conversely, shrinking artifacts are evident in al-
coholic fixatives, and the entity of shrinkage is more evi-
dent when the alcohol concentration is higher than 50%.
Also, Zinc-based formulas showed evident shrinkage of
tissues (Figure 3).
For Immunohistochemistry (Figures 3 third column, 4,
and 5), we had the advantage of utilizing routine staining
protocols of an automated immunostainer (Ventana
Benchmark - Diapath, Italy) already tailored for samples
fixed with FineFixx (for surgical pathology antigens) or
Carnoy Fixative for neuropathology (GFAP, Synaptophy-
sin, Neu-N, HuC/HuD, Pituitary hormones etc.).
Nucleic Acid Extraction: as already reported in the sci-
entific literature alcohol-based fixatives, as well as most
of the proprietary formulas, are superior to formalin
with regard to quality and quantity of Nucleic acid ex-
tractable from paraffin blocks. Similarly to RCL2, CellBlock (a glyoxale-based fixative) and PAGA-T were also
superior to formalin in RNA preservation.
We focused on RNA extraction – an essential step for
retro-transcription - due to higher sensitivity to denatur-
ation and easy decay of this nucleic acid. Ribonucleic
acid extraction confirmed that most of the fixatives
tested were comparable or superior to formalin as far as
quantity of RNA extracted was concerned. In Table 1
and Figure 3 the quantitative and qualitative results of
RNA extraction are shown.
The qualitative analysis of RNA by RNA Chip (Figure 6)
showed RIN values spanning from 1.80 of PAGA-A to
2.50 of Neo-Fix, with CellBlock and formalin with a RIN
of 2.2 and RCL2 of 2.30.
The striking difference of performance between
PAGA-T (PAGA with buffer) and PAGA-A (with greater
percentage of acetic acid) is interesting because it under-
scores the fact that a small difference in composition
may influence the preservation of Nucleic Acids, while
morphology itself is unaffected.
All fixatives tested permitted Q-RT-PCR to be per-
formed for the 3 genes - beta2microglobulin, ribosomal
protein S14 and glyceraldehyde phosphate dehydrogen-
ase (GAPDH) - of increasing length of transcripts (data
not shown).
Although these aspects of tissue integrity at the mo-
lecular level may be crucial for the application of mo-
lecular biology techniques for large quantities of surgical
pathology specimens, other aspects of tissue handling
may be relevant for morphological evaluation and easy
tissue handling. The lag of time from sampling to proper
fixation should be taken in account as well as the pro-
cessing steps prior to paraffin inclusion [29]. Large vari-
ability of chemicals used in the processing steps, timing
and temperature settings may have a non-marginal influ-
ence on the conservation of molecular constituents of
tissues, and should be investigated and possibly standar-
dized as far as possible. However, it appears to be diffi-
cult to find and standardize fixation and processing
protocols suitable for routine surgical practices, which
are thus refined to preserve tissue constituents as well as
“snap freezing” procedures. The use of the HOPE tech-
nique is a promising alternative to bio-banking but not
suitable for routine use [40]. The use of microwaves in
tissue handling is very promising but may be not prac-
tical for busy labs unless dedicated instruments are
available.
Discussion
The key problem of fixation without formaldehyde is
represented by the modifications of the tissues that alter
their morphological aspect, when compared to what is
routinely considered their standard counterparts. Any
method of fixation or general handling of biological
Figure 2 Molds growing on the surface of fixative. In a jar containing tissues fixed in ZBF one week after sampling a large colony of fungi is
evident (top). Detail of upper and lower aspects of the colony (bottom).
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modifications in the composition of the tissues that will
alter their morphological aspect, and the formalin stand-
ard is quite variable from laboratory to laboratory as an
average distribution.
Formalin, or more precisely buffered-formalin, follows
the same rules but there is a general agreement that
these artefacts are in some way standardized and accept-
able as a “gold standard”. This widespread opinion has
been solid enough to be interpreted as a “dogma”, in
that this has become an opinion without a solid scien-
tific background.
The enthusiasm for this new, highly versatile molecule,
which allowed the use of a single fixative for different
histochemical stains developed with dedicated fixatives
was certainly justified in the two last centuries [41].
However, modern pathology relies on a wealth of new,
sophisticated and predictive tools that may by applied
on properly fixed tissues with different formulations of
fixatives including formaldehyde-free ones.
One important point of this opinion that holds true is
the necessity of standardization of the overall tissue pro-
cessing steps, from the time gap from surgery to the
staining, in order to homogenize the diagnostic evalu-
ation and define a uniform diagnostic criteria.
The weakness of the “formalin dogma” is the fact that
from many points of view formalin is not the best fixa-
tive but simply the most utilized. One aspect is the qual-
ity of microscopic slides and the accuracy and care of
the fixation process: the limited penetration speed of
fixatives should become an important intrinsic property
of every fixative, and positive actions must be performedin order to permit adequate fixation in large and com-
plex surgical specimens. However a somewhat fatalistic
approach to the fixation process is the strongest motiv-
ation for formalin use, that is: when the specimen is
immersed in an appropriate amount of formalin, the
most important step of fixation is thus fulfilled.
Another aspect to be considered is the fact that forma-
lin is actually a class of formaldehyde-based fixatives
with a final aldehyde concentration of 4%. The most
commonly used and recommended recipe is neutral-
buffered formalin that is a 4% solution with the addition
of a buffer (generally phosphate), to give a stable final
pH close to neutrality. Different formulations are used
under the general name of formalin, so the general
agreement on “formalin fixation” is a somewhat very
large and generic method encompassing quite different
fixation conditions and practices. Moreover, the ready–
to-use, commercially available, neutral-buffered formalin
may not be equivalent or have standardized formulas,
since some modifications of the composition are intro-
duced by manufacturers in order to obtain a long-lasting
product, suitable for use in laboratories for months or
even years after production. Conversely, creating home-
made recipes from 40% formaldehyde and tap or dis-
tilled water plus buffer may be time-consuming in
preparation but may be more consistent over time, and
freshly prepared without the necessity of stabilizing
agents to ensure a long “shelf-life”.
One important issue to be considered is the determin-
ation of predictive or prognostic factors for targeted
therapy of tumors and the necessity of reliable data that
does not rely on the choice of fixative. The methylation
Figure 3 Histological sections of a case of Myeloma. Tissue fixed with Cell-Block, PAGA-T, PAGA-A, RECL2, Z7 and Formalin. Differences in
tissue coarctation and nuclear details, as well as color affinity, are evident upon Haematoxylin- Eosin (H&E) and Giemsa (1stand 2 nd column)
staining. Although formalin fixation shows less tissue shrinkage in comparison to alcoholic fixatives, along with a lower affinity to eosin, nuclear
details are less well-preserved. In sections stained with Giemsa, Cell-Block, Formalin and Z7 are bluish in color and other fixatives tend to be
pinkish. Giemsa is a pH-sensitive stain with a predominant blue hue with basic or neutral pH which turns to pink with a lower pH, as with RCL2
and PAGA that contain Acetic Acid at different concentrations. Nuclear details (as nucleoli) are sharper in formalin substitutes. Also the Golgi
apparatus is more evident as paranuclear “hof”. Immunoperoxidase staining for lambda light chain (3rd column): strong positivity is present on all
samples with some variation in cellular details and background. Immunostaining with automated procedure set for formalin-fixed tissues.
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(MGMT) in gliomas is a validated predictive response
factor to chemotherapy. The report on the use of RCL2
in formalin substitution has demonstrated better per-
formance of this alternative fixative in comparison to
formalin [24]. The same applies in the comparison ofCarnoy or FineFixx gliomas with formalin-fixed tumors.
The peculiarity of a Pediatric Pathology Unit hampered
the possibility of recruiting breast samples in this study
for investigating the performance of the alternative fixa-
tives in that particular context. We did however have
the opportunity to study Her-2 expression in samples of
Figure 4 Immunostaining for Baf47 nuclear antigen. As expected no nuclear positivity is present in samples of a Rhabdoid Tumor of the
kidney. Only endothelial nuclei are positive in all samples. Positive infiltrating lymphocytes are present and highlighted in the RCL2 sample. Other
tumor samples such as Neuroblastoma (PAGA and RCL2, second row) Wilm's tumor (Z7) and ductal carcinoma (Formalin) as well as normal testis
(FineFixx) show uniform nuclear positivity. [Manual antigen retrieval with microwave treatment in EDTA buffer pH 8.5.].
Zanini et al. Environmental Health 2012, 11:59 Page 10 of 14
http://www.ehjournal.net/content/11/1/59breast carcinoma fixed in FineFixx. With adequate con-
trols of positive breast tumors fixed in parallel in buf-
fered formalin and Fine-Fixx and the validated
immunistochemistry (Ventana, Martinengo,Italy) we
obtained comparable results. ASCO-CAP guidelines [42]
favor formalin fixation but do not exclude the use ofFigure 5 Immunostaining for WT-1. In Wilm's tumor (Cell-Block, PAGA an
glomeruli of normal kidney (Z7 and ZBF). Some tubular cells are positive in
microwave treatment in EDTA buffer pH 8.5.].different fixatives, recommending careful comparison
and tight adherence to procedures and their validation
for achieving proper and consistent results not influ-
enced by fixation procedure. Even when formalin is
used, the time of fixation should be tightly controlled
(permitted range 6 – 48 hours). Accurate selection ofd ZBF) staining is more intense in glomerular-like structures and in
the medulla only in PAGA-fixed tissue. [Manual antigen retrieval with
Table 1 Formulations of alternative fixatives discussed in
study
Cell-Block RCL-2 ZBF Z7 PAGA-T Fine-Fixx
Ethyl Alcohol 50 62,5 - - 56 70
Glyoxale + - - - - -
Acetic acid - 5,00% - - 2,50% -
Zn Cloride - - 0,50% 0,50% - -
Zn acetate - - 0,50% - - -
Zn trifluoroacetate 0,50%
Glycerol - - - - 4,00% -
PEG - - - - 20,00% -
Trealose - + - - - -
wetting agents - - - - - +
buffer - - Tris–HCl Tris–HCl Tris–HCl -
undisclosed + ? - - - ?
formaldehyde - - - - - -
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the use of adequate controls may also permit the correct
determination and interpretation of Herb-2 determina-
tions [43] with alternative fixation formulas. As pointed
out by oncologists, FISH determinations are less sensi-
tive to fixation variables and its results are more relevant
to biological responses of tumors to anti-Herb2Figure 6 Results of RNA 6000 LabChip analysis. RNAs extracted from dtreatments [44]. The better preservation of nucleic acids
obtained with alternative fixatives should be an ulterior
point in favor of formaldehyde substitution as the pri-
mary fixative, as well as in the determination of molecu-
lar prognostic or predictive factors with in situ
hybridization.
Recently, an innovative processing instrumentation
has been proposed for large pathology departments. The
system developed in Japan is based on microwave treat-
ment and the proprietary formalin substitute (UMFIX=
universal molecular fixative - Sakura Finetek USA, Inc.):
a mixture of methanol and polyethylene glycol at a pre-
determined ratio [45]. In this way, an innovation intro-
duced by industry as part of a cutting-edge processing
procedure is undermining the “formalin dogma” with
apparent no relevant opposition.
As a corollary to the introduction of UMFIX, it is also
interesting to note that this fixative is not freely available
on the market, but only sold to users of the system as a
dedicated product. In fact we were intent on using
UMFIX in our study, but were unable to obtain it from
the national representative of the producer in Italy.
Another point to be considered is the use of formalde-
hyde in developing countries in which aspiration devices
(hoods and aspirated cabinets) are rarely used and the
disposal of toxic waste may also be inexistent or prob-
lematic [31].ifferent fixatives show different RIN and electrophoresis curves.
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(as is the case of some of the “homemade” substitutes)
may be of benefit in these laboratories and be economic-
ally sustainable even in low income environments.
These are ideal times for a general effort in finding new
more suitable fixatives that are less harmful, not only for
morphological and immunohistochemical evaluation but,
on the same note, for the preservation of important tissue
components, allowing the widespread use of new tech-
nologies for diagnostic or scientific aims. A widespread
effort towards practical scientific progress may improve
the working environment of grossing and autopsy rooms,
reduce or abolish the use of carcinogenic compounds,
and be a concrete step towards more controlled proces-
sing procedures. Many of the commercially-available for-
malin substitutes are suitable for use in diagnostic
purposes in routine histological practices. Conversely to
the general opinion of the positive effects of free market,
the use of proprietary formulas has been a real obstacle to
generalized formalin substitution, as well as creating a
higher cost of formalin substitutes. The possibility of pre-
paring several different fixatives in the laboratory, and
testing them with different tissues and working conditions
should be underscored as a practical alternative to com-
mercial products. This also overcomes the limited avail-
ability of some industrial products outside the USA, as
well as the difficulties and relevant costs of transport and
storage of highly flammable liquids.
The option of using a few different fixatives depending
on specific pathological sectors may also be a positive
step towards abolishing or significantly decreasing the
use of formaldehyde.
Zinc-based fixatives, alcohol-tensioactive based and
formulas including acetic acid and alcohol as important
components, or glyoxale +/− alcohol appear to be suit-
able for general fixation, and may be effective alternatives
to formalin as commercial products or laboratory-made
reagents.
The conservation of important molecular tissue com-
ponents appears to be superior in new fixatives when
compared to formalin. The goal of a fixative suitable for
routine diagnostic procedures, but that also preserves
RNA, DNA and proteins, as well as in snap-frozen tis-
sue samples, may be difficult to achieve immediate-
ly. However, the selection of less drastic fixatives, and
the improvement and standardization of processing pro-
cedures, may preserve nucleic acids, and possibly pro-
teins in order to integrate new techniques to routine
surgical pathology determinations. Integrity of delicate
tissue components may also be improved by combining
new fixatives and physical agents like cooling and
vacuum treatments when the time delay from theater
to pathology laboratory may be critical. Microwave
treatment is another possible processing method, butfrozen tissue still remains more suitable for selected
fields like proteomics.
Conclusion
Our study demonstrates that several alternative fixa-
tives are available as patented industrial products or
as reagents easily prepared in the laboratory from
chemicals present in the market. These fixatives are
suitable for routine use for surgical pathology diag-
nostic work.
Although morphology may show fixation artefacts dif-
ferent from that induced by formalin fixation no real
thread to surgical pathology diagnoses may be taken in
consideration. Conversely alternative fixatives perform
equally o better than formalin in all ancillary techniques
used by modern pathologists.
No rational reasons hamper the complete substitution
of formaldehyde as primary fixative in surgical pathology
and in the medical research using laboratory animals.
Times are ripe for the abolition of a carcinogen to
human beings from Pathology Departments and re-
search laboratories.
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